Introduction
Early detection of LV diastolic dysfunction is crucial for the management of patients with heart disease. PC-CMR is increasingly used for this evaluation. However, its usefulness in clinical routine is not established yet because of technical issues such as the lack of automated post-processing tools. We hypothesized that the analysis of velocity and flow-rate curves extracted from an accurate segmentation of the transmitral flow would provide sensitive diastolic parameters.
Methods
We studied 35 healthy controls (21 women; age: 38±16 years) and 12 consecutive patients (8 women; age: 81±5 years) with a severe aortic stenosis (valve area/body surface=0.47±0.17 cm 2 /m 2 , ejection fraction=66±16%, enddiastolic volume=94±18 ml, end-systolic volume=33±19 ml). All subjects had an echocardiography (GE Vivid 7) and a transmitral flow PC-CMR acquisition (GE 1.5 T) on the same day. For PC-CMR images analysis, we used our custom software for semi-automated segmentation of transmitral flow and automated extraction of diastolic parameters from velocity and flow rate curves. Flow rate curves provided: 1) peak filling rate (Ef MR , ml/s) and peak atrial filling rate (Af MR , ml/s) combined into Ef MR / Af MR , 2) peak filling rate to filling volume ratio (Ef MR / FVf MR , s -1 ), and 3) the deceleration time (DTf MR ), while maximal velocity curves provided the early and late peak velocities E MR and A MR , combined into E MR /A MR . DT US and E US /A US as well as the flow to tissue velocity ratio E US /E' US were estimated from Doppler echocardiography.
Results
A stronger correlation and a slope closer to 1 was found for the comparison between the echocardiographic E US /A US and the flow rate-related Ef MR /Af MR (r=0.80, Ef MR /Af MR =0.89·E US /A US +0.09) than the velocity-related E MR /A MR (r=0.72, E MR /A MR =0.55·E US /A US +0.49). Results of receiver operating characteristic (ROC) analysis summarized in table 1 indicated the good sensitivity and specificity of the PC-CMR parameters to separate controls from patients.
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